that doesn't say BP. Previously, Dr. Rae was th
Post# of 148297
Quote:
that doesn't say BP.
Quote:
Previously, Dr. Rae was the Executive Director of NPS Pharmaceuticals and Head of GI and Endocrinology Business Development until the acquisition by Shire Pharmaceuticals for $5.2 billion in 2015.
Shire Pharmaceuticals was valued at $62 billion by Takeda Pharmaceuticals when they bought it out. That's not tiny.